Clinical trial
A Randomized, Within Subject Controlled, Dose Regimen Study of SLI-F06 in Healthy Volunteers for Improvement in Scar Appearance
NCT05501327 is registered in ClinicalTrials.gov with Scarless Laboratories, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Within Subject Controlled, Dose Regimen Study of SLI-F06 in Healthy Volunteers for Improvement in Scar Appearance
- Lead sponsor
- Scarless Laboratories, Inc.
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 25, 2022
- Completion date
- October 25, 2024
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
scar, wound healing